Value-Based Reimbursement: The Three Key Strategy Questions

Value-based reimbursement (VBR) seems to be getting a boost during this pandemic period—and likely thereafter. For me, one sign was the announcement by the Medicare Payment Advisory Commission (MedPAC) of its proposal to revert to pre-pandemic telehealth restrictions for fee-for-service provider organizations but to continue to allow expanded options for provider organizations participating in advanced alternative payment models.

During the pandemic, Blue Cross Blue Shield of Massachusetts (BCBSMA) announced plans to pilot a new value-based payment model (in lieu of fee-for-service payments) for small primary care practices. The model offers an immediate . . .